Results 171 to 180 of about 2,084 (194)
Some of the next articles are maybe not open access.

One-year clinical outcomes of iStent infinite® versus iStent inject® in open-angle glaucoma

Journal Français d'Ophtalmologie
To compare the clinical outcomes of the iStent inject® and the iStent infinite® in a homogeneous population of patients with mild-to-moderate primary open-angle glaucoma (POAG), assessing the additive effect of a third trabecular micro-bypass stent.Retrospective comparative study between eyes submitted to iStent inject® (group 1) or iStent infinite ...
R Augusto Paletta, Guedes   +4 more
openaire   +2 more sources

iStent surgery as an option for mild to moderate glaucoma

Expert Review of Ophthalmology, 2013
Surgery with the iStent (Glaukos Corporation, Laguna Hills, CA, USA), a trabecular bypass stent, has been added as an option for the treatment of mild to moderate glaucoma. It is a 1 mm titanium stent used to directly shunt aqueous from the anterior chamber into Schlemm’s canal.
Kevin Kaplowitz   +3 more
openaire   +1 more source

CCO-based analog front-end for iStents

2017 32nd Conference on Design of Circuits and Integrated Systems (DCIS), 2017
This paper presents a low power analog front-end designed to be part of an intelligent stent for restenosis monitoring in a distal pulmonary artery. The heterogeneous front-end comprises a capacitive MEMS pressure sensors for the acquisition of physiological signals, as well as 0.18 μm CMOS electronics for wireless device powering and data transmission,
J. A. Miguel   +3 more
openaire   +1 more source

Phaco + iStent implant learning curve in a teaching hospital

European Journal of Ophthalmology
Purpose iStent inject ® W is a minimally invasive surgical device aimed at creating an alternative trabecular drainage of aqueous humour, reducing intraocular pressure (IOP)
Diogo Bernardo Matos   +7 more
openaire   +2 more sources

Predictors of success of iStent and iStent inject, when combined with cataract surgery

Clinical & Experimental Ophthalmology, 2020
Philip Rothschild   +5 more
openaire   +2 more sources

Comparison Of Intraocular Pressure Lowering Effect And Complications Between Istent Inject W And Istent

2022
Kiyoshi Ishii   +6 more
openaire   +1 more source

iStent inject beim phaken Offenwinkelglaukom (K)

2015
28.
Klamann, MKJ   +5 more
openaire   +1 more source

Comparison of surgical outcomes between iStent and iStent inject W with ≥2 years of follow-up: a propensity score matching analysis

Japanese Journal of Ophthalmology
To compare real-world outcomes between first-generation iStent (G1) and iStent inject W (G2) combined with cataract surgery.Retrospective, propensity score-matched clinical investigation.Consecutive eyes treated with phaco-iStent (G1) or phaco-iStent inject W (G2) were matched 1:1 (n=115 per group) for age, preoperative intraocular pressure (IOP ...
Hiroshi Kasai   +6 more
openaire   +2 more sources

Short-Term Outcomes And Prognostic Factors Of Cataract-Combined Surgery With Istent Versus Istent Inject

2022
Jinhee Lee   +6 more
openaire   +1 more source

iStent for Adults With Glaucoma: A Health Technology Assessment.

Ontario health technology assessment series, 2021
Glaucoma is a condition that causes progressive damage to the optic nerve, which can lead to visual impairment and potentially to irreversible blindness. The iStent and iStent inject are devices implanted in the eye during a type of minimally invasive glaucoma surgery (MIGS) to reduce intraocular pressure by increasing trabecular outflow by bypassing ...
openaire   +1 more source

Home - About - Disclaimer - Privacy